BIT
IMNP

BlackRock Institutional Trust’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

BlackRock Institutional Trust’s Portfolio IMNP Stock Details IMNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-197
Closed -$5K – 4000
2015
Q3 		$5K Hold
197
– – ﹤0.01% 3926
2015
Q2 		$8K Hold
197
– – ﹤0.01% 3890
2015
Q1 		$7K Buy
+197
New +$7.36K ﹤0.01% 3828

Other funds holding IMNP

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IFS
Ifrah Financial Services Little Rock, Arkansas $409M AUM 28.15% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

BlackRock Institutional Trust's IMNP Position: Q4 2015 in Review

BlackRock Institutional Trust sold out of Immune Pharmaceuticals Inc. (IMNP) in Q4 2015, closing a stake of 197 shares — an estimated $5K sold.

BlackRock Institutional Trust first reported a position in IMNP in Q1 2015 and held it in 3 quarters. The position peaked at $8K in Q2 2015. 15 funds tracked by Wall St. Rank hold IMNP as of Q4 2015.

  • BlackRock Institutional Trust reported no remaining Immune Pharmaceuticals Inc. position as of Q4 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 197 Immune Pharmaceuticals Inc. shares in Q4 2015, an estimated $5K.
  • BlackRock Institutional Trust first reported a position in Immune Pharmaceuticals Inc. in Q1 2015 and held it in 3 quarters.
  • BlackRock Institutional Trust's Immune Pharmaceuticals Inc. position peaked at $8K in Q2 2015.
  • 15 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q4 2015.

Based on BlackRock Institutional Trust's 13F filing for Q4 2015, filed 11 Feb 2016.